Journal
BMJ OPEN
Volume 3, Issue 9, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2013-003055
Keywords
-
Categories
Funding
- Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, Cancer Surveillance Branch, Atlanta, GA
- Louisiana Tumor Registry, School of Public Health, Louisiana State University, New Orleans, LA [U58/CCU 62(306)]
- CDC/NPCR Atlanta, GA
- New York State Cancer Registry, New York State Department of Health, Albany, NY [U58/CCU 220322]
- Colorado Central Cancer Registry, Colorado Department of Public Health and Environment, Denver, CO [U58/CCU 820326]
- Illinois State Cancer Registry, Illinois Department of Public Health, Springfield, IL [U58/CCU 520378]
- South Carolina Central Cancer Registry, Columbia
- SC [U58/CCU 420312]
- California Cancer Registry, Sacramento, CA [U58/CCU 920352]
- Rhode Island Cancer Registry, Rhode Island Department of Health, Providence, RI [U58/CCU 520378]
- University of Kentucky, Lexington KY [UKRF 3049024672-12-568]
- Health Department of the Navarra Government, Spain [79/2000]
- Estonian Ministry of Education and Research [SF0940026s07]
- Cancer Research UK [16148, 11700] Funding Source: researchfish
Ask authors/readers for more resources
Objectives: To assess the extent to which stage at diagnosis and adherence to treatment guidelines may explain the persistent differences in colorectal cancer survival between the USA and Europe. Design: A high-resolution study using detailed clinical data on Dukes' stage, diagnostic procedures, treatment and follow-up, collected directly from medical records by trained abstractors under a single protocol, with standardised quality control and central statistical analysis. Setting and participants: 21 population-based registries in seven US states and nine European countries provided data for random samples comprising 12 523 adults (15-99 years) diagnosed with colorectal cancer during 1996-1998. Outcome measures: Logistic regression models were used to compare adherence to 'standard care' in the USA and Europe. Net survival and excess risk of death were estimated with flexible parametric models. Results: The proportion of Dukes' A and B tumours was similar in the USA and Europe, while that of Dukes' C was more frequent in the USA (38% vs 21%) and of Dukes' D more frequent in Europe (22% vs 10%). Resection with curative intent was more frequent in the USA (85% vs 75%). Elderly patients (75-99 years) were 70-90% less likely to receive radiotherapy and chemotherapy. Age-standardised 5-year net survival was similar in the USA (58%) and Northern and Western Europe (54-56%) and lowest in Eastern Europe (42%). The mean excess hazard up to 5 years after diagnosis was highest in Eastern Europe, especially among elderly patients and those with Dukes' D tumours. Conclusions: The wide differences in colorectal cancer survival between Europe and the USA in the late 1990s are probably attributable to earlier stage and more extensive use of surgery and adjuvant treatment in the USA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available